Pharmaceuticals
French report on improving access to drug information published
16 October 2018 - Posted by: Eveline Van Keymeulen
The French Minister of Healthcare recently announced the publication of a report on improving access for patients and healthcare professionals to information on medicinal products. The report includes, in particular, recommendations on how to improve the information content (targets, quality, verification and so on) and evolution (especially during a health crisis), as well as access › Read More
French ATU procedure simplified to ensure rapid patient access to innovations
04 October 2018 - Posted by: Eveline Van Keymeulen
On 17 September 2018, the National Agency for Medicines and Health Products Safety (ANSM) introduced a single portal for health care professionals to apply for individual temporary authorisations for use (ATUs) with the aim of increasing transparency and simplifying the processing of ATU applications to ensure earlier management of patients likely to benefit from new › Read More
19 September 2018 - Posted by: Jacqueline Bore
CRISPR-Cas9 is a remarkable gene editing technology which has the potential to revolutionise the development of medicines, particularly those for genetic diseases and cancer. Pharmaceutical companies have been quick to partner with innovators who have begun to find ways to commercialize CRISPR-Cas9, both as a research tool and as a route to the development of › Read More
11 September 2018 - Posted by: Emma Keeling
As big data continues to be big news and data protection law continues to evolve, it is timely that the Department for Health and Social Care (the Department) has published a code of conduct relating to the use of data-driven health and care technology (the Code). Published in its initial form on Wednesday, the code › Read More
New directive on GMP transposed into Belgian law
05 September 2018 - Posted by: Tine Carmeliet
On 20 July 2018, the Royal Decree of 27 June 2018, which implements Commission Directive 2017/1572 as regards the principles and guidelines of good manufacturing practice for medicinal products for human use (GMP Directive), was published. The decree should have been implemented on 31 March 2018, when the GMP Directive entered into force. While the › Read More